Live Breaking News & Updates on Ericj Feldman|Page 2
Stay updated with breaking news from Ericj feldman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
GlycoMimetics, inc (GLYC) Q2 2021 Earnings Call Transcript fool.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fool.com Daily Mail and Mail on Sunday newspapers.
GlycoMimetics, inc (GLYC) Q2 2021 Earnings Call Transcript fool.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fool.com Daily Mail and Mail on Sunday newspapers.
Press release content from Business Wire. The AP news staff was not involved in its creation. Positive Findings From Phase 1b Trial of GlycoMimetics’ GMI-1359 To Be Presented at AACR 2021 Meeting April 10, 2021 GMT ROCKVILLE, Md. (BUSINESS WIRE) Apr 10, 2021 GlycoMimetics, Inc. (Nasdaq: GLYC) today announces that a Phase 1b trial of GMI-1359, being conducted at Duke University Cancer Center, showed evidence of on-target effects, immune-activation and cell mobilization in the initial two patients treated with the Company’s dual antagonist of E-selectin and CXCR4. Dorothy Sipkins, MD, PhD, Associate Research Professor in Pharmacology and Cancer Biology at Duke University School of Medicine, will present results from the proof-of-concept clinical study as well as a separate preclinical study supporting the positive biologic findings of the Phase 1b study. The presentation will be made at the American Association of Cancer Research (AACR) 2021 Annual Meeting, whic ....
[Operator Instructions] I would now like to turn the call over to Shari Annes of the Investor Relations group at GlycoMimetics. Please go ahead. Shari Annes Thank you. Good morning. Today, we will review our accomplishments and financial results for both the three and 12-month periods ended December 31, 2020. We ll also update you on recent [Indecipherable]. The press release we issued this morning is available on the company s website at www.glycomimetics.com, under the Investors tab. This call is being recorded. A dial-in phone replay will be available for 24 hours after the close of the call. The webcast replay will also be available on the Investor Relations section of the company s website for 30 days. ....